In Depth 4 Jan 2021 What Does the Next Decade Have in Store for European Biotech? …identify drug candidates against a specific target. This can significantly reduce the time it takes to select a drug candidate to start clinical testing. A recent example is that of… January 4, 2021 - 9 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
News and Trends 28 Mar 2018 AI Is Being Put to Work to Treat Parkinson’s Disease in the UK The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is… March 28, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2022 Nykode Therapeutics and Richter-Helm BioLogics announce partnership …compliance for clinical trials and late-stage product candidates,” said Kai Pohlmeyer, managing director of Richter-Helm BioLogics. Manufacturing is a strategic focus area for Nykode and its license partners. Under the… December 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 May 2023 Five recent advancements in arthritis research over the past year …Month in May, here are five recent advancements in arthritis research over the past year. Acelyrin’s drug candidate advances in phase 2 clinical trials for psoriatic arthritis treatment For the… May 22, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2019 German Cancer Virotherapy Biotech Launches with €12M Series A …the arenavirus candidates that Abalos is developing will rely on the patient’s immune system to target cancer cells. According to the company, replication of its arenavirus candidates in the targeted… October 15, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2022 Aqemia raises €30M for AI-enabled drug discovery pipeline …said its ambition is to optimize and accelerate early drug discovery projects on a massive scale in order to uncover dozens of proprietary new drug candidates. Those candidates will fuel… October 19, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2022 Global Team-up Cuts Genomics Costs to Fight Salmonella Infections …mixed results in a phase I trial in 2002, and the program was dropped thereafter. There are now several ongoing programs; the most advanced candidate is in a phase I… February 10, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? …more stable and longer-lasting vaccine candidates than mRNA, and it also means that less of the genetic material is required with circular RNA, which could lead to more vaccines being… August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2024 Biotech bankruptcies: what to expect in 2024 following a record year? …in funds that were predicted to run on until 2025 to develop its three cancer drug candidates, was scrapped by MEI because it failed to win stockholder approval. Following layoffs,… March 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2017 New British Biotech Enters the Clinic with Opioid Alternative for Chronic Pain Levicept’s Phase I study will test their new pain relief candidate’s safety and tolerability in healthy individuals and osteoarthritis patients. Levicept, based in Sandwich, UK, focuses on the development of… September 15, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2017 Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis …and Active Biotech’s multiple sclerosis candidate failed at Phase III, but the news that Roche’s candidate, Ocrevus, was approved by the FDA will have raised the spirits in the field…. November 1, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2018 ProQR Tackles Blindness Caused by a Rare Genetic Disease …that has caught the attention of the US-based charity, Foundation Fighting Blindness. The two have come together to develop ProQR’s candidate, QR-421a, which targets blindness caused by the condition. The… February 13, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email